SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
31-May-24 4:18 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 29-May-24 | Grant | 49,220 | -- | -- | 3% 1.93M to 1.98M | |
16-Aug-23 8:53 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 16-Aug-23 | Gift | 50,000 | -- | -- | 5% 1.11M to 1.16M | |
16-Aug-23 8:53 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 16-Aug-23 | Purchase | 388,889 | $0.90 | $350,000.00 | 34% 1.16M to 1.54M | |
16-Aug-23 8:53 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 16-Aug-23 | Purchase | 388,889 | $0.90 | $350,000.00 | 25% 1.54M to 1.93M | |
05-Jul-22 4:11 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 05-Jul-22 | Private Purchase | 238,095 | $2.10 | $499,999.00 | 52% 462.11K to 700.21K | |
08-Jul-21 6:17 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion | 130,180 | -- | -- | 1822% 7.14K to 137.32K | |
08-Jul-21 6:17 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion | 131,595 | -- | -- | 96% 137.32K to 268.92K | |
08-Jul-21 6:17 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Purchase | 35,000 | $16.00 | $560,000.00 | 13% 268.92K to 303.92K | |
17-Aug-20 4:39 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 14-Aug-20 | Market Purchase | 15,700 | $6.38 | $100,166.00 | 4% 446.41K to 462.11K | 88% |
17-Aug-20 4:39 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 13-Aug-20 | Market Purchase | 15,550 | $6.45 | $100,298.00 | 4% 430.86K to 446.41K | 86% |
12-Nov-19 4:40 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition (change in control) | 635,665 | $27.50 | $17,480,800.00 | (100%) 635.66K to 0 | |
07-Jan-19 8:54 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 07-Jan-19 | Market Purchase | 9,221 | $10.45 | $96,386.00 | 2% 421.64K to 430.86K | 18% |
21-Dec-18 5:07 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 20-Dec-18 | Market Purchase | 31,000 | $6.26 | $194,060.00 | 5% 604.66K to 635.66K | 27% |
19-Jun-18 4:50 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 19-Jun-18 | Conversion | 394,295 | -- | -- | 1442% 27.34K to 421.64K |